Healthcare provider profile · identity verified

Jason Servi, DO

Family Practice · MERRILL, WI · NPI 1811554850

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	252	84
Losartan Potassium	Losartan Potassium	201	68
Amlodipine Besylate	Amlodipine Besylate	153	52
Levothyroxine Sodium	Levothyroxine Sodium	116	34
Tamsulosin Hcl	Tamsulosin Hcl	112	29
Metoprolol Succinate	Metoprolol Succinate	106	37
Hydrochlorothiazide	Hydrochlorothiazide	98	36
Lisinopril	Lisinopril	98	40
Omeprazole	Omeprazole	93	34
Gabapentin	Gabapentin	90	23
Furosemide	Furosemide	87	27
Pantoprazole Sodium	Pantoprazole Sodium	82	27
Duloxetine Hcl	Duloxetine Hcl	76	14
Clonazepam	Clonazepam	64	suppressed
Potassium Chloride	Potassium Chloride	60	17
Oxycodone Hcl	Oxycodone Hcl	55	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	51	20
Pregabalin	Pregabalin	50	suppressed
Metformin Hcl	Metformin Hcl	49	18
Rosuvastatin Calcium	Rosuvastatin Calcium	48	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	13
Albuterol Sulfate Hfa	Albuterol Sulfate	45	21
Metformin Hcl Er	Metformin Hcl	44	17
Oxybutynin Chloride Er	Oxybutynin Chloride	42	suppressed
Warfarin Sodium	Warfarin Sodium	42	14
Glipizide Er	Glipizide	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	19
Trazodone Hcl	Trazodone Hcl	39	17
Hydroxyzine Hcl	Hydroxyzine Hcl	37	suppressed
Simvastatin	Simvastatin	36	12
Allopurinol	Allopurinol	35	13
Eliquis	Apixaban	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	17
Buspirone Hcl	Buspirone Hcl	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Lorazepam	Lorazepam	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	11
Sertraline Hcl	Sertraline Hcl	29	suppressed
Prednisone	Prednisone	28	25
Doxycycline Monohydrate	Doxycycline Monohydrate	27	25
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Meloxicam	Meloxicam	23	suppressed
Topiramate	Topiramate	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	21
Terazosin Hcl	Terazosin Hcl	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Famotidine	Famotidine	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Ozempic	Semaglutide	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Carvedilol	Carvedilol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error